Yes. That's a report that was prepared by Rx and D. It's called the “International Report on Access to Medicines” and it is from 2010. For drugs for mental illness, which is where the Alzheimer's disease drugs are ranked within that group, they were ranked at 27 out of 29 in terms of access for Canadians to those drugs.
On November 15th, 2011. See this statement in context.